Jubilant Ingrevia
Jubilant Ingrevia Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Jubilant Ingrevia Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Jubilant Ingrevia Ltd trades at a P/E of 35.59× and P/B of 3.15×.
Valuation
Profitability
Growth
Financial Health
Jubilant Ingrevia Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Jubilant Ingrevia Ltd, switchable between annual and quarterly views, consolidated or standalone.
Jubilant Ingrevia Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹10,176.47 Cr and reported EPS of ₹17.52.
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 684 | 4,949 | 4,773 | 4,136 | 4,178 | 4,388 |
| Other Income | 3 | 31 | 33 | 35 | 38 | 41 |
| Total Income | 687 | 4,981 | 4,806 | 4,171 | 4,215 | 4,429 |
| Cost of Goods Sold (COGS) | 370 | 2,794 | 2,582 | 2,143 | 2,107 | 2,295 |
| Gross Profit | 314 | 2,155 | 2,191 | 1,993 | 2,070 | 2,093 |
| +Operating Expenses | 197 | 1,323 | 1,644 | 1,572 | 1,551 | 1,526 |
| EBITDA | 117 | 832 | 547 | 421 | 519 | 567 |
| +Non-Operating Expenses | 16 | 154 | 144 | 189 | 213 | 212 |
| Profit Before Tax (PBT) | 77 | 709 | 437 | 268 | 344 | 370 |
| +Tax Expense | 23 | 232 | 129 | 85 | 92 | 92 |
| Profit After Tax (PAT) | 54 | 477 | 308 | 183 | 251 | 278 |
| Earnings Per Share (EPS) | 3.41 | 29.93 | 19.31 | 11.48 | 15.77 | 17.45 |
| Diluted Shares Outstanding (Nos.) | 16 | 16 | 16 | 16 | 16 | 16 |
| +Additional Disclosures | 971 | 7,162 | 6,953 | 6,050 | 5,981 | 6,361 |
| Sales Growth % | — | 623.45 | -3.57 | -13.34 | 1.01 | 5.04 |
| YoY Sales Growth % | — | 623.45 | -3.57 | -13.34 | 1.01 | 5.04 |
| Material Cost % | 53 | 57 | 53 | 49 | 49 | 48 |
| Employee Cost % | 7 | 7 | 7 | 9 | 10 | 10 |
| Other Cost % | 22 | 20 | 27 | 29 | 27 | 25 |
| OPM % | 17 | 17 | 11 | 10 | 12 | 13 |
| Tax % | 30 | 33 | 30 | 32 | 27 | 25 |
| Profit Growth % | — | 776.95 | -35.50 | -40.52 | 37.33 | 10.65 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 95 | 708 | 425 | 285 | 361 | 392 |
Jubilant Ingrevia segment analysis: revenue and profit mix.
Disclosed business segments at Jubilant Ingrevia with their share of revenue and profit, switchable between consolidated and standalone reporting.
Jubilant Ingrevia discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Jubilant Ingrevia Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Jubilant Ingrevia Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Jubilant Ingrevia Ltd's investment case rests on 8 positive markers and 8 flagged concerns drawn from the latest reported filings.
What you're getting.
Jubilant Ingrevia shows robust quarterly profit growth of 17.80%, reflecting strong operational efficiency. A healthy OPM of 13.20% further indicates a sustainable business model in specialty chemicals.
The company maintains a manageable debt-to-equity ratio of 0.26, suggesting financial prudence and stability. This low leverage provides flexibility for future growth and capital expenditures.
With a market capitalization of ₹10978 crore, Jubilant Ingrevia holds a significant position in the specialty chemicals sector, indicating a strong market presence and investor confidence.
Quarterly sales grew by 7.22% to ₹1121 crore, demonstrating consistent revenue generation and a stable market position. This steady growth indicates a reliable customer base.
The specialty chemicals sector, where Jubilant Ingrevia operates, is experiencing robust growth, driven by increasing demand from diverse end-user industries like pharmaceuticals and agriculture.
What can break it.
Promoter holding has recently decreased to 45.22% from 51.47%, which might be a concern for some investors regarding management's long-term commitment or potential future dilution.
The stock has experienced significant price volatility, ranging from a high of ₹885 to a low of ₹535 in the past year, posing a risk for investors seeking stable and consistent returns.
Net profit has shown volatility, declining from ₹92 crore in Dec 2022 to ₹29 crore in Mar 2024, then recovering to ₹69 crore in Sep 2025. This inconsistent profitability warrants close monitoring.
A price-to-book value of 3.75 indicates a premium valuation, suggesting the market expects strong future growth. This could make the stock vulnerable to corrections if performance falls short.
Intense competition from established players like Pidilite Industries and Deepak Nitrite, some with higher ROCE, could pressure margins and market share in the specialty chemicals sector.
What would change my mind.
Trim if P/E re-rates above 46. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 25.83. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Jubilant Ingrevia Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Jubilant Ingrevia Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Jubilant Ingrevia Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Jubilant Ingrevia Ltd — derived from the live tape, not yesterday's close.
Jubilant Ingrevia Ltd last traded at ₹638.2 with an intraday range of ₹617.5–₹641.45 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹638.20| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 695.17 | +56.97 | +8.93% |
| R3 | 671.22 | +33.02 | +5.17% |
| R2 | 656.33 | +18.13 | +2.84% |
| R1 | 647.27 | +9.07 | +1.42% |
| PIVOT | 632.38 | -5.82 | -0.91% |
| CURRENT | 638.20 | — | — |
| S1 | 575.42 | -62.78 | -9.84% |
| S2 | 599.37 | -38.83 | -6.08% |
| S3 | 608.43 | -29.77 | -4.66% |
| S4 | 623.32 | -14.88 | -2.33% |
JUBLINGREA is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 627.45 ~ 635.85
Trading Above opening range, showing Bullishness
Jubilant Ingrevia Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Jubilant Ingrevia Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Jubilant Ingrevia Ltd stood at 60.2% of traded volume, against a 20-day average of 51.5%.
Jubilant Ingrevia announcements: results, concalls, ratings, M&A.
Filings Jubilant Ingrevia sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Jubilant Ingrevia files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 178 documents below.
Copy of Newspaper Publication
Jubilant Ingrevia Limited has informed the Exchange about Copy of Newspaper Publication
Investor Presentation
Jubilant Ingrevia Limited has informed the Exchange about Investor Presentation
Press Release
Jubilant Ingrevia Limited has informed the Exchange regarding a press release dated May 26, 2026, titled "Press release and presentation on the…
Outcome of Board Meeting
Jubilant Ingrevia Limited has informed the Exchange regarding Outcome of Board Meeting held on May 26, 2026.
Appointment
Jubilant Ingrevia Limited has informed the Exchange regarding Appointment of M/s J.K. Kabra & Co. as Cost Auditors of the company for FY 2026-27
Investor decks & rating reports.
Jubilant Ingrevia insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Jubilant Ingrevia as reported to SEBI — buying and selling signals from the people who know the business best.
Jubilant Ingrevia insider activity below tracks 50 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Jubilant Ingrevia Employees Welfare Trust | Insider | 23 Mar 2026 | buy | +10.0 K | ₹56.21 L | ₹562.09 |
| Jubilant Ingrevia Employees Welfare Trust | Insider | 23 Mar 2026 | buy | +10.0 K | ₹56.21 L | ₹562.09 |
| Jubilant Ingrevia Employees Welfare Trust | Insider | 23 Mar 2026 | buy | +10.0 K | ₹56.21 L | ₹562.09 |
| Jubilant Ingrevia Employees Welfare Trust | Insider | 23 Mar 2026 | buy | +10.0 K | ₹56.21 L | ₹562.09 |
| Jubilant Ingrevia Employees Welfare Trust | Insider | 20 Mar 2026 | buy | +25.0 K | ₹1.45 Cr | ₹581.66 |
| Jubilant Ingrevia Employees Welfare Trust | Insider | 20 Mar 2026 | buy | +25.0 K | ₹1.45 Cr | ₹581.66 |
| Jubilant Ingrevia Employees Welfare Trust | Insider | 20 Mar 2026 | buy | +25.0 K | ₹1.45 Cr | ₹581.66 |
| Jubilant Ingrevia Employees Welfare Trust | Insider | 20 Mar 2026 | buy | +25.0 K | ₹1.45 Cr | ₹581.66 |
| Jubilant Ingrevia Employees Welfare Trust | Insider | 19 Mar 2026 | buy | +50.0 K | ₹2.89 Cr | ₹578.86 |
| Jubilant Ingrevia Employees Welfare Trust | Insider | 19 Mar 2026 | buy | +50.0 K | ₹2.89 Cr | ₹578.86 |
Jubilant Ingrevia dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Jubilant Ingrevia has declared, sequenced by announce and record date.
Jubilant Ingrevia corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Jubilant Ingrevia Ltd: business, sector, key facts.
What Jubilant Ingrevia Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Jubilant Ingrevia Ltd operates in the Basic Materials, listed as NSE: JUBLINGREA, BSE: 543271.
Jubilant Ingrevia Limited (formerly Jubilant LSI Limited) is a global life sciences company operating across India, the United States, Europe, and China. The company's core business centers on the development, manufacture, and supply of a diverse range of specialty chemicals, nutrition & health solutions, and chemical intermediates. This multifaceted approach allows them to serve a wide spectrum of industries.
Their Specialty Chemicals segment is a significant contributor, offering a comprehensive portfolio including bio-pyridine and -picolines, fine chemicals, agrochemicals, and custom development and manufacturing services. This segment also encompasses solutions for microbial control, highlighting a focus on both the development of specific chemical compounds and the provision of tailored solutions to meet specific customer needs.
The Nutrition & Health Solutions segment focuses on the production and supply of ingredients and solutions for both human and animal nutrition. This involves a range of products, from vitamins (such as Vitamin B3 and B4) and minerals to premixes, antioxidants, and other specialized nutritional components. The company's expertise extends to providing solutions for stress regulation and enhancing egg quality in animal feed, demonstrating a commitment to various market segments within the nutrition sector.
The Chemical Intermediates segment provides essential building blocks for various industries. Their offerings include acetyls, specialty ethanol, and a wide array of pyridine derivatives with diverse functional groups (cyano, acetyl, amino, halo, alkyl, and aldehyde). This segment emphasizes the supply of fundamental chemicals that form the basis for many downstream applications.
In addition to product offerings, Jubilant Ingrevia provides comprehensive services, including route design, process development, optimization, and scale-up for commercial manufacturing of intermediates. This integrated approach differentiates them by offering end-to-end solutions, supporting clients throughout the entire process from initial concept to large-scale production.
Jubilant Ingrevia serves a diverse client base across pharmaceutical, animal and human nutrition, agrochemical, personal and consumer care, and industrial sectors. Their broad product and service portfolio combined with their global reach establishes them as a significant player in the life sciences industry.
Questions investors ask about Jubilant Ingrevia Ltd (JUBLINGREA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Jubilant Ingrevia Ltd (JUBLINGREA)?
The current share price of Jubilant Ingrevia Ltd (JUBLINGREA) is ₹638.2. Today, the stock has gained by ₹14.80 (2.37%), trading in a range of ₹617.5 to ₹641.45. The stock opened at ₹630 with a trading volume of 6,16,476 shares.
02Is Jubilant Ingrevia Ltd stock a good investment for long-term?
Jubilant Ingrevia Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹10,176.47 crores, P/E ratio of 35.59, ROE of 9.18%, and ROCE of 11.20%. The dividend yield stands at 0.80%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Jubilant Ingrevia Ltd stock?
The 52-week high price of Jubilant Ingrevia Ltd (JUBLINGREA) is ₹851.8, while the 52-week low is ₹537.3. Currently trading at ₹638.2, the stock is 32.1% away from its 52-week low and 25.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Jubilant Ingrevia Ltd stock at the current price?
Whether to buy Jubilant Ingrevia Ltd stock at ₹638.2 depends on multiple factors. The stock is currently trading with a P/E ratio of 35.59 and P/B ratio of 3.15. Today's performance shows a gain of 2.37%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Jubilant Ingrevia Ltd and when is the next dividend?
Jubilant Ingrevia Ltd offers a dividend yield of 0.80%, which means for every ₹100 invested at the current price of ₹638.2, you can expect to receive approximately ₹0.80 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Jubilant Ingrevia Ltd?
Jubilant Ingrevia Ltd's key financial metrics include: P/E Ratio: 35.59, P/B Ratio: 3.15, ROE: 9.18%, ROCE: 11.20%, Dividend Yield: 0.80%, EPS: ₹17.52, Book Value: ₹197.83, and Debt-to-Equity: 25.33. The company's market cap stands at ₹10,176.47 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Jubilant Ingrevia Ltd stock performing today in the market?
Jubilant Ingrevia Ltd stock opened at ₹630 and is currently trading at ₹638.2, showing a gain of ₹14.80 (2.37%). The intraday high is ₹641.45 and low is ₹617.5. The trading volume stands at 6,16,476 shares, indicating moderate market participation today.
08What is the P/E ratio of Jubilant Ingrevia Ltd and what does it indicate?
Jubilant Ingrevia Ltd has a Price-to-Earnings (P/E) ratio of 35.59, which means investors are willing to pay ₹35.59 for every ₹1 of earnings. With an EPS of ₹17.52, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Jubilant Ingrevia Ltd (JUBLINGREA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarti Industries (AARTIIND) Share PricePeer
- Aarti Surfactants (AARTISURF) Share PricePeer
- Archean Chemical Industries (ACI) Share PricePeer
- Aether Industries (AETHER) Share PricePeer
- Alkali Metals (ALKALI) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy